N. ODA

1.5k total citations
34 papers, 1.3k citations indexed

About

N. ODA is a scholar working on Molecular Biology, Cancer Research and Immunology and Allergy. According to data from OpenAlex, N. ODA has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Cancer Research and 9 papers in Immunology and Allergy. Recurrent topics in N. ODA's work include Angiogenesis and VEGF in Cancer (10 papers), Cell Adhesion Molecules Research (9 papers) and Protease and Inhibitor Mechanisms (8 papers). N. ODA is often cited by papers focused on Angiogenesis and VEGF in Cancer (10 papers), Cell Adhesion Molecules Research (9 papers) and Protease and Inhibitor Mechanisms (8 papers). N. ODA collaborates with scholars based in Japan and Sweden. N. ODA's co-authors include Mayumi Abé, Yasufumi Sato, Shinichi Kanno, Koichi Tabayashi, Kenya Shitara, Mikito Ito, Yoshito Terai, Masabumi Shibuya, Toshikuni Yonemoto and Takahiro Kawakatsu and has published in prestigious journals such as Circulation, The Journal of Immunology and PLoS ONE.

In The Last Decade

N. ODA

34 papers receiving 1.2k citations

Peers

Countries citing papers authored by N. ODA

Since Specialization

Citations

This map shows the geographic impact of N. ODA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. ODA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. ODA more than expected).

Fields of papers citing papers by N. ODA

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. ODA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. ODA. The network helps show where N. ODA may publish in the future.

Co-authorship network of co-authors of N. ODA

This figure shows the co-authorship network connecting the top 25 collaborators of N. ODA. A scholar is included among the top collaborators of N. ODA based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. ODA. N. ODA is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells 2016 ·PLoS ONE ·Hidenori Fujita, Akira Gomori, (unknown), Yuki Kataoka, (unknown), Akihiro Hashimoto, Takamasa Suzuki, Kenjiro Ito, (unknown), (unknown), Naomoto Harada, (unknown), N. ODA, Kenichi Matsuo, Masaki Inada, Kazuhiko Yonekura	15
2	Evaluation of animal models for intestinal first-pass metabolism of drug candidates to be metabolized by CYP3A enzymes viain vivoandin vitrooxidation of midazolam and triazolam 2013 ·Xenobiotica ·(unknown), Tatsuro Mutoh, Toru Takenaka, N. ODA, Nobumitsu Hanioka, S. Narimatsu	5
3	Prostate growth inhibition by subtype‐selective alpha ₁ ‐adrenoceptor antagonist naftopidil in benign prostatic hyperplasia 2009 ·The Prostate ·Yoshiyuki Kojima, Shoichi Sasaki, N. ODA, Taka‐aki Koshimizu, Yutaro Hayashi, Mamoru Kiniwa, Gozoh Tsujimoto, Kenjiro Kohri	33
4	PROSTATE GROWTH INHIBITION BY SUBTYPE-SELECTIVE ALPHA1-ADRENOCEPTOR ANTAGONIST NAFTOPIDIL IN BENIGN PROSTATIC HYPERPLASIA 2009 ·The Journal of Urology ·Yoshiyuki Kojima, Shoichi Sasaki, N. ODA, (unknown), Yasue Kubota, Yutaro Hayashi, Mamoru Kiniwa, Kenjiro Kohri	4
5	Augmented Binding and Activation of Latent Transforming Growth Factor-β by a Tryptic Fragment of Latency Associated Peptide 2002 ·Endothelium ·Mayumi Abé, N. ODA, Yasufumi Sato, Kenji Shibata, (unknown)	13
6	The effect of the hydrophobicity of microchannels and components in water and oil phases on droplet formation in microchannel water-in-oil emulsification 2001 ·Colloids and Surfaces A Physicochemical and Engineering Aspects ·Takahiro Kawakatsu, Gun Trägårdh, C. Trägårdh, Mitsutoshi Nakajima, N. ODA, Toshikuni Yonemoto	112
7	Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells 2000 ·Oncogene ·Shinichi Kanno, N. ODA, Mayumi Abé, Yoshito Terai, Mikito Ito, Kenya Shitara, Koichi Tabayashi, Masabumi Shibuya, Yasufumi Sato	240
8	Properties of Two VEGF Receptors, Flt‐1 and KDR, in Signal Transduction^a 2000 ·Annals of the New York Academy of Sciences ·Yasufumi Sato, Shinichi Kanno, N. ODA, Mayumi Abé, Mikito Ito, Kenya Shitara, Masabumi Shibuya	109
9	Signal Transduction and Transcriptional Regulation of Angiogenesis 2000 ·Advances in experimental medicine and biology ·(unknown), Mayumi Abé, (unknown), (unknown), N. ODA, Shinichi Kanno, M. Oikawa, Tohru Nakano, (unknown)	46
10	ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin ?3 1999 ·Journal of Cellular Physiology ·N. ODA, Mayumi Abé, Yasufumi Sato	183
11	ETS‐1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3 1999 ·Journal of Cellular Physiology ·N. ODA, Mayumi Abé, Yasufumi Sato	2
12	Establishment of a Simple and Practical Procedure Applicable to Therapeutic Angiogenesis 1999 ·Circulation ·Shinichi Kanno, N. ODA, Mayumi Abé, Sachiko Saito, Katsuyoshi Hori, Yasunobu Handa, Koichi Tabayashi, Yasufumi Sato	125
13	Cell-associated activation of latent transforming growth factor-β by calpain 1998 ·Journal of Cellular Physiology ·Mayumi Abé, N. ODA, Yasufumi Sato	67
14	Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury 1998 ·Journal of Cellular Physiology ·Katsuhiro Tanaka, N. ODA, (unknown), Mayumi Abé, Yasufumi Sato	80
15	TAS-301, an Inhibitor of Smooth Muscle Cell Migration and Proliferation, Inhibits Intimal Thickening after Balloon Injury to Rat Carotid Arteries 1998 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Yasundo Yamasaki, Yoshihisa Nozawa, (unknown), (unknown), N. ODA, Atsushi Satoh, Tetsuji Asao, Hidekazu Miyake, Naosuke Matsuura	13
16	Calcium entry blocking activities of MPC-1304 and of its enantiomers and metabolites 1993 ·European Journal of Pharmacology ·(unknown), (unknown), (unknown), N. ODA, (unknown)	15
17	SYNTHESIS OF METABOLITES OF MPC-1304,A NEW CALCIUM ANTAGONIST, AND RELATED COMPOUNDS AND OPTICAL RESOLUTION OF MPC-1304 AND RELATED COMPOUNDS 1991 ·Journal of Pharmacobio-Dynamics ·(unknown), (unknown), (unknown), (unknown), N. ODA	2
18	Effect of flunarizine on the attenuation of baroreflex by transient cerebral ischemia 1989 ·European Journal of Pharmacology ·(unknown), N. ODA, (unknown)	3
19	ChemInform Abstract: Synthesis of Coumarins by Nucleophilic Denitrocyclization Reaction. 1987 ·ChemInform ·N. ODA, Yukio Yoshida, S. NAGAI, Takuya Ueda, Jinsaku Sakakibara	1
20	ChemInform Abstract: Bridgehead Nitrogen Heterocycles. Synthesis of Methanoazepines Fused with Tetrazole, 1,2,4‐Triazole and 1,2,4‐Triazine. 1986 ·Chemischer Informationsdienst ·S. NAGAI, Nobuo Kato, T. UEDA, N. ODA, Jinsaku Sakakibara	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact